Single Cell Sequencing Market Size to Reach USD 6,193.01 Million in 2032

Vancouver, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global single-cell sequencing market is expected to reach USD 6,193.01 Million by 2032, according to a new report by Emergen Research. Single-cell sequencing finds widespread use in resolving heterogeneity of tumor, reconstruction of cancer cell evolutionary courses, and identification of rare sub-clones, thereby providing a promising technique for addressing resistance to drugs.

Recently, researchers at the University of South California (USC) have developed a method using single-cell sequencing to identify sub-clones in cancer tissue that could provide important biological insights into how cancer progresses, how it spreads, and why it can become resistant to treatment.

Increased investment in the R&D activities by the companies in the single-cell sequencing industry crucial in driving the growth of the market. For instance, 10X Genomics, a leading biotech firm engaged in the design and production of tech for genome sequencing, reported that its R&D expenditures rose to USD 22.2 million in the third quarter 0f 2019 from USD 11.1 million in 2018 during the same period, fueled by increased funding in workforce hiring, infrastructure development, and supplies.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/140

Scope of Research

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/140

Major Companies and Competitive Landscape

The leading players in the single-cell sequencing market are equipped with enhanced production facilities and are involved in various R&D activities.

A few leading players in the single-cell sequencing market include:

• Illumina
• Thermo Fisher Scientific Inc.
• Fludigim
• Bio-Rad
• Becton, Dickinson, & Company
• Qiagen
• F Hoffman-La Roche Ltd.
• BGI
• 10X Genomics Inc.
• Oxford Nanopore Technologies

Strategic Development

In February 2018, PerkinElmer entered into an agreement for the acquisition of RHS for worth USD 19.7 million. The deal is intended to expand the genomic research offerings of PerkerElmer with the RHS’s single-cell genomics technologies.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/140

Some Key Highlights from the Report

• Single-cell isolation aids in achieving cell viability of 99.0% without interfering with whole genome amplification, polymerase chain reaction (PCR), or whole transcriptome amplification (WTA) reactions and therefore held a substantial share of the market in 2019.
• The next-generation sequencing (NGS) technology has drawn the attention of many companies and investors in various fields, including fundamental research, discovery, and production of pharmaceutical drugs, reproductive, and consumer genomics.
• Instruments, in terms of revenue, held a larger market share in 2019, owing to the development and usage of advanced tools and solutions in the treatment of various chronic and infectious diseases.
• Single-cell sequencing enables the categorization of cell types, as well as subtypes in the central nervous system at the transcriptome level, thereby aiding to solve issues associated with the complexity and heterogeneity of the nervous system and find out the brain formation mechanisms at various stages of developmental.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@  https://www.emergenresearch.com/industry-report/single-cell-sequencing-market

Emergen Research has segmented the global single-cell sequencing market on the basis of product type, workflow, technology, disease type, application, end-use, and region:

• Product Type Outlook (Revenue, USD Billion; 2017-2032)
  • Reagents
  • Instruments
• Workflow Outlook (Revenue, USD Billion; 2017-2032)
  • Single Cell Isolation
  • Sample Preparation
  • Genomic Sequencing
• Technology Outlook (Revenue, USD Billion; 2017-2032)
  • Sequencing
  • qPCR
  • Microarray
  • MDA
  • PCR
• Disease Type Outlook (Revenue, USD Billion; 2017-2032)
  • Oncology
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Others
• Application Outlook (Revenue, USD Billion; 2017-2032)
  • Circulating Cells
  • Cell Differentiation/Reprogramming
  • Subpopulation Characterization
  • Genomic Variation
  • Others
• End Use Outlook (Revenue, USD Billion; 2017-2032)
  • Academic & Research Laboratories
  • Hospitals & Clinics
  • Biopharmaceutical & Biotechnology Companies
  • Others
• Regional Outlook (Revenue, USD Billion; 2017-2032)
  • North America
    1. U.S.
    2. Canada
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Curated Reports You Shouldn't Miss: Dive In Now!

Surgical Robots Market, By Product and Services (Robotic Systems, Instruments, and Services), By Surgery Type (Urology Surgery and Neurosurgery), By End-use, and By Region Forecast to 2030

Veterinary Reference Laboratory Market, By Technology (Clinical Chemistry, Hematology, and Others), By Application (Clinical Pathology, Toxicology, and Others), By Animal Type, and By Region Forecast to 2032

Medical Vacuum System Market, By Product Type (Standalone Vacuum System and Portable Vacuum System), By Technology (Dry Claw Vacuum Pump Technology), By Application, By End-use, and By Region Forecast to 2032

Restorative Dentistry Market, By Product (Restorative Materials, Restorative Materials, and Others), By Application (Endodontics and Conservative, Prosthodontics, and Others) By End-Use, and By Region Forecast to 2030

Environmental Deoxyribonucleic Acid DNA eDNA Biomonitoring Market, By Sample Type (Water, Soil, and Air), By Technology, By Application, and By Region Forecast to 2032

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Single Cell Sequencing Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-single-cell-sequencing-market